ABSTRACT

The current study was undertaken to explore and compile the research evidence on Psidium guajava in the management of diabetes. To undertake the said aim, peer-reviewed literatures were retrieved during January 2023 from PubMed, Science Direct and Springer databases. The obtained literature was initially subjected to title and abstract screening, followed by full-text screening. The study includes eight articles that used in vivo research on animal models. In these researches, the antidiabetic property was evaluated using either leaf or fruit. The available evidence conclusively demonstrates the potential of Psidium guajava against diabetes as it holds significant glucose-lowering effects in the reported screened models. Bioactivity-guided fractionation followed by elucidation of the mechanism of action will be useful in establishing the application of the plant species in diabetes. Keywords: Psidium guajava, systematic review, diabetes, in vivo model
Publication date: 01/09/2024

https://ijbpas.com/pdf/2024/September/MS_IJBPAS_2024_8310.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2024/13.9.8310